March 19, 2019

Circassia finds a second way to put investors’ money under threat

Business development decisions have started the clock on a financial time bomb set to go off within the next three months.

June 18, 2015

Novartis’s triple push has an unusual target

February 13, 2015

Upcoming events: Genfit in liver disease and Astra's new respiratory play

February 10, 2015

Glaxo tries to turn a triple play

August 14, 2014

Interview – Unshackled SkyePharma goes hunting

August 04, 2014

Boehringer plays catch-up on multiple fronts

July 30, 2014

Astra’s bargain basement move sends competition a message

July 16, 2014

Glaxo and Theravance raise the respiratory stakes

July 07, 2014

No respite for private biotech takeovers